annual CFO:
-$142.11M-$65.35M(-85.13%)Summary
- As of today (May 29, 2025), SMMT annual cash flow from operations is -$142.11 million, with the most recent change of -$65.35 million (-85.13%) on December 31, 2024.
- During the last 3 years, SMMT annual CFO has fallen by -$69.52 million (-95.77%).
- SMMT annual CFO is now -1036.40% below its all-time high of $15.18 million, reached on January 31, 2017.
Performance
SMMT Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$61.17M-$12.49M(-25.67%)Summary
- As of today (May 29, 2025), SMMT quarterly cash flow from operations is -$61.17 million, with the most recent change of -$12.49 million (-25.67%) on March 31, 2025.
- Over the past year, SMMT quarterly CFO has dropped by -$31.03 million (-102.99%).
- SMMT quarterly CFO is now -277.77% below its all-time high of $34.41 million, reached on October 31, 2016.
Performance
SMMT quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$173.14M-$31.03M(-21.84%)Summary
- As of today (May 29, 2025), SMMT TTM cash flow from operations is -$173.14 million, with the most recent change of -$31.03 million (-21.84%) on March 31, 2025.
- Over the past year, SMMT TTM CFO has dropped by -$79.38 million (-84.66%).
- SMMT TTM CFO is now -682.48% below its all-time high of $29.72 million, reached on July 31, 2017.
Performance
SMMT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SMMT Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -85.1% | -103.0% | -84.7% |
| 3 y3 years | -95.8% | -221.9% | -144.1% |
| 5 y5 years | -584.6% | -1133.5% | -627.4% |
SMMT Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -241.8% | at low | -1278.3% | at low | -384.8% | at low |
| 5 y | 5-year | -584.6% | at low | -1278.3% | at low | -627.4% | at low |
| alltime | all time | -1036.4% | at low | -277.8% | at low | -682.5% | at low |
SMMT Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$61.17M(+25.7%) | -$173.14M(+21.8%) |
| Dec 2024 | -$142.11M(+85.1%) | -$48.67M(+60.7%) | -$142.11M(+25.9%) |
| Sep 2024 | - | -$30.30M(-8.2%) | -$112.89M(+15.8%) |
| Jun 2024 | - | -$33.00M(+9.5%) | -$97.49M(+4.0%) |
| Mar 2024 | - | -$30.13M(+54.9%) | -$93.76M(+22.2%) |
| Dec 2023 | -$76.76M(+84.6%) | -$19.46M(+30.6%) | -$76.76M(+47.3%) |
| Sep 2023 | - | -$14.90M(-49.1%) | -$52.11M(+13.9%) |
| Jun 2023 | - | -$29.27M(+122.9%) | -$45.77M(+28.2%) |
| Mar 2023 | - | -$13.13M(-353.0%) | -$35.71M(-14.1%) |
| Dec 2022 | -$41.58M(-42.7%) | $5.19M(-160.7%) | -$41.58M(-25.7%) |
| Sep 2022 | - | -$8.55M(-55.5%) | -$55.95M(-21.2%) |
| Jun 2022 | - | -$19.22M(+1.1%) | -$70.96M(+0.1%) |
| Mar 2022 | - | -$19.00M(+107.0%) | -$70.92M(-2.3%) |
| Dec 2021 | -$72.59M(+50.9%) | -$9.18M(-61.0%) | -$72.59M(+1.7%) |
| Sep 2021 | - | -$23.57M(+22.9%) | -$71.38M(+10.7%) |
| Jun 2021 | - | -$19.17M(-7.2%) | -$64.46M(+1.0%) |
| Mar 2021 | - | -$20.67M(+159.3%) | -$63.82M(+32.7%) |
| Dec 2020 | -$48.11M(+131.8%) | - | - |
| Dec 2020 | - | -$7.97M(-52.1%) | -$48.11M(+19.9%) |
| Sep 2020 | - | -$16.65M(-10.2%) | -$40.14M(+25.0%) |
| Jun 2020 | - | -$18.53M(+273.7%) | -$32.10M(+34.9%) |
| Mar 2020 | - | -$4.96M(-42.4%) | -$23.80M(-0.9%) |
| Dec 2019 | -$20.76M(-40.9%) | - | - |
| Oct 2019 | - | -$8.61M(-15.8%) | -$24.02M(+19.5%) |
| Jul 2019 | - | -$10.23M(-667.1%) | -$20.10M(-15.3%) |
| Apr 2019 | - | $1.80M(-125.9%) | -$23.72M(-32.4%) |
| Jan 2019 | -$35.11M | - | - |
| Jan 2019 | - | -$6.98M(+48.6%) | -$35.11M(-5.0%) |
| Oct 2018 | - | -$4.70M(-66.1%) | -$36.96M(-19.7%) |
| Jul 2018 | - | -$13.86M(+44.7%) | -$46.05M(+131.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2018 | - | -$9.58M(+8.5%) | -$19.88M(-3.4%) |
| Jan 2018 | -$20.58M(-235.6%) | - | - |
| Jan 2018 | - | -$8.83M(-36.0%) | -$20.58M(+11.4%) |
| Oct 2017 | - | -$13.79M(-211.9%) | -$18.47M(-162.1%) |
| Jul 2017 | - | $12.32M(-219.8%) | $29.72M(+109.3%) |
| Apr 2017 | - | -$10.28M(+53.1%) | $14.20M(-6.4%) |
| Jan 2017 | $15.18M(-162.0%) | - | - |
| Jan 2017 | - | -$6.72M(-119.5%) | $15.18M(+3.5%) |
| Oct 2016 | - | $34.41M(-1172.5%) | $14.67M(-156.1%) |
| Jul 2016 | - | -$3.21M(-65.5%) | -$26.13M(-6.1%) |
| Apr 2016 | - | -$9.31M(+28.8%) | -$27.82M(+13.7%) |
| Jan 2016 | -$24.47M(+47.5%) | - | - |
| Jan 2016 | - | -$7.23M(+13.1%) | -$24.47M(+12.7%) |
| Oct 2015 | - | -$6.39M(+30.5%) | -$21.71M(+17.4%) |
| Jul 2015 | - | -$4.90M(-17.9%) | -$18.48M(-8.2%) |
| Apr 2015 | - | -$5.96M(+33.5%) | -$20.13M(+21.4%) |
| Jan 2015 | -$16.59M(+71.3%) | - | - |
| Jan 2015 | - | -$4.46M(+41.1%) | -$16.59M(+36.8%) |
| Oct 2014 | - | -$3.16M(-51.6%) | -$12.12M(+35.3%) |
| Jul 2014 | - | -$6.54M(+170.8%) | -$8.96M(+270.8%) |
| Apr 2014 | - | -$2.42M | -$2.42M |
| Jan 2014 | -$9.68M(+92.3%) | - | - |
| Jan 2013 | -$5.03M(+32.4%) | - | - |
| Jan 2012 | -$3.80M(-12.3%) | - | - |
| Jan 2011 | -$4.34M(+63.9%) | - | - |
| Jan 2010 | -$2.65M(-82.0%) | - | - |
| Jan 2009 | -$14.72M(-8.7%) | - | - |
| Jan 2008 | -$16.13M(+170.6%) | - | - |
| Jan 2007 | -$5.96M(+266.4%) | - | - |
| Jan 2006 | -$1.63M(-2978.2%) | - | - |
| Jan 2005 | $56.50K | - | - |
FAQ
- What is Summit Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Summit Therapeutics?
- What is Summit Therapeutics annual CFO year-on-year change?
- What is Summit Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Summit Therapeutics?
- What is Summit Therapeutics quarterly CFO year-on-year change?
- What is Summit Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Summit Therapeutics?
- What is Summit Therapeutics TTM CFO year-on-year change?
What is Summit Therapeutics annual cash flow from operations?
The current annual CFO of SMMT is -$142.11M
What is the all time high annual CFO for Summit Therapeutics?
Summit Therapeutics all-time high annual cash flow from operations is $15.18M
What is Summit Therapeutics annual CFO year-on-year change?
Over the past year, SMMT annual cash flow from operations has changed by -$65.35M (-85.13%)
What is Summit Therapeutics quarterly cash flow from operations?
The current quarterly CFO of SMMT is -$61.17M
What is the all time high quarterly CFO for Summit Therapeutics?
Summit Therapeutics all-time high quarterly cash flow from operations is $34.41M
What is Summit Therapeutics quarterly CFO year-on-year change?
Over the past year, SMMT quarterly cash flow from operations has changed by -$31.03M (-102.99%)
What is Summit Therapeutics TTM cash flow from operations?
The current TTM CFO of SMMT is -$173.14M
What is the all time high TTM CFO for Summit Therapeutics?
Summit Therapeutics all-time high TTM cash flow from operations is $29.72M
What is Summit Therapeutics TTM CFO year-on-year change?
Over the past year, SMMT TTM cash flow from operations has changed by -$79.38M (-84.66%)